The State of China Biotech 2010 - Part I
Driving factors and government programs
on January 27, 2010
China’s life science industry is moving quickly from services to innovation. In the 2010 ChinaBio Executive Workshop "Leveraging China to Build a Global Biotech", hosted at Morrison & Foerster's San Francisco office during the 28th JP Morgan Healthcare Conference, Greg Scott presents the latest update on China's government programs, novel technology development, investment, M&A and partnering deals, and other data from ChinaBio’s research team.
Watch this video series for not only hot-off-the-press facts and figures, but also stories and anecdotes witnessed or experienced by a pioneering firm, on the frontline of bio-business in the world's fastest growing but complex country.
Tags: China, ChinaBio, China, ChinaBio, Greg Scott, China biotech, MOST, Ministry of Science and Technology, Chine Academy of Sciences, CAS, China Academy of Medical Sciences, CAMS, Mega New Drug Development Program, MNDDP, Zhangjiang Hi-Tech Park, Zhongguancun